Business News • PR NewsWire • LUMICKS Collaborates with AstraZeneca and the University of Cambridge to Form the First Ever Center of Excellence for Dynamic Single-Molecule Analysis for Accelerated Drug Discovery and Biology

LUMICKS Collaborates with AstraZeneca and the University of Cambridge to Form the First Ever Center of Excellence for Dynamic Single-Molecule Analysis for Accelerated Drug Discovery and Biology

LUMICKS Collaborates with AstraZeneca and the University of Cambridge to Form the First Ever Center of Excellence for Dynamic Single-Molecule Analysis for Accelerated Drug Discovery and Biology

AMSTERDAM, June 27, 2018 /PRNewswire/ -- The center will be based around LUMICKS' C-Trap™ optical tweezers-fluorescence microscope, which for the first time enables real-time observation and probing of biomolecular interactions. The approach will be pioneered in several...

View More : https://www.prnewswire.com/news-releases/lumicks-collaborates-with-astrazeneca-and-the-university-of-cambridge-to-form-t...

Releted News by prnewswire

Verve Industrial Protection Announces the Release of Version 6.0 - The First True End Point Management Detection and Response Platform for Industrial IOT & Industrial Control Systems

Berlin Cures strengthens Business Advisory Board with the appointments of Ulf Berg, Ph.D., and Dragan Grabulovski, Ph.D.

4D Presents at IHMC 2018

LUMICKS Collaborates with AstraZeneca and the University of Cambridge to Form the First Ever Center of Excellence for Dynamic Single-Molecule Analysis for Accelerated Drug Discovery and Biology